Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
3.69M
-
Shares change
-
+160K
-
Total reported value, excl. options
-
$22.2M
-
Value change
-
+$875K
-
Put/Call ratio
-
0
-
Number of buys
-
21
-
Number of sells
-
-19
-
Price
-
$6.02
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q3 2025
59 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q3 2025.
Nuvectis Pharma, Inc. - COM (NVCT) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.69M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (699K shares), BlackRock, Inc. (685K shares), IRIDIAN ASSET MANAGEMENT LLC/CT (406K shares), BALDWIN WEALTH PARTNERS LLC/MA (350K shares), GEODE CAPITAL MANAGEMENT, LLC (326K shares), Occam Crest Management LP (290K shares), STATE STREET CORP (137K shares), NORTHERN TRUST CORP (107K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (90.9K shares), and OPPENHEIMER & CO INC (69.1K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.